Elsayed Soliman to Anti-Arrhythmia Agents
This is a "connection" page, showing publications Elsayed Soliman has written about Anti-Arrhythmia Agents.
Connection Strength
0.123
-
Limpitikul WB, Dewland TA, Vittinghoff E, Soliman E, Nah G, Fang C, Siscovick DS, Psaty BM, Sotoodehnia N, Heckbert S, Stein PK, Gottdiener J, Hu X, Hempfling R, Marcus GM. Premature ventricular complexes and development of heart failure in a community-based population. Heart. 2022 Jan; 108(2):105-110.
Score: 0.050
-
Snitker S, Doerfler RM, Soliman EZ, Deo R, St Peter WL, Kramlik S, Fischer MJ, Navaneethan S, Delafontaine P, Jaar BG, Ojo A, Makos GK, Slaven A, Weir MR, Zhan M, Fink JC. Association of QT-Prolonging Medication Use in CKD with Electrocardiographic Manifestations. Clin J Am Soc Nephrol. 2017 09 07; 12(9):1409-1417.
Score: 0.038
-
Qureshi W, O'Neal WT, Soliman EZ, Al-Mallah MH. Systematic review and meta-analysis of mortality and digoxin use in atrial fibrillation. Cardiol J. 2016; 23(3):333-43.
Score: 0.035